Financial release accessible
online
BOSTON, Feb. 6, 2025
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced
that financial results for its third quarter fiscal year 2025,
which ended December 28, 2024, are
available on its Investor Relations website.
The Company will host a conference call and webcast with
investors and analysts to discuss and answer questions about the
results at 8:00 a.m. ET on
February 6, 2025. The conference call
and webcast can be accessed with the following information:
- Teleconference
link: https://register.vevent.com/register/BIda08929a4d56464eb33eccb945ef985e
- Once registration is completed, participants will receive a
dial-in number along with a personalized PIN to access the call.
While not required, it is recommended that participants join 10
minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics'
investor relations website or via the following link:
https://edge.media-server.com/mmc/p/63jte4ra
In addition, the Company has posted to its Investor Relations
website the earnings release that will be referenced on its
conference call and webcast, a link to which is available
below.
Direct link to 3Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/36134646-a371-4076-87b9-26673f9f10f3
A replay of the conference call and webcast will be available
for one year beginning on February 6,
2025, at 11:00 a.m. ET using
the conference call webcast link provided in this press
release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
|
Investor
Contacts:
|
|
|
Olga Guyette, Vice
President-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781) 356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson, Sr.
Director-Global
Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302368961.html
SOURCE Haemonetics Corporation
